CLSD

1.02

3.03% 0.03

Dopo l'orario di chiusura: 1.02

Clearside Biomedical Inc (CLSD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.99

Aprire:

$0.99

Volume 24 ore:

346.86K

Relative Volume:

0.47

Capitalizzazione di mercato:

$75.49M

Reddito:

$8.23M

Utile/perdita netta:

$-32.49M

Rapporto P/E:

-1.7288

EPS:

-0.59

Flusso di cassa netto:

$-19.91M

1 W Prestazione:

-6.42%

1M Prestazione:

-11.30%

6M Prestazione:

-22.14%

1 anno Prestazione:

+7.00%

Intervallo 1D:

$0.99

$1.04

Intervallo di 1 settimana:

$0.9757

$1.16

Portata 52W:

$0.92

$2.12

Clearside Biomedical Inc Stock (CLSD) Company Profile

Nome

Clearside Biomedical Inc

Settore

Healthcare (1196)

Industria

Biotechnology (683)

Telefono

678-270-3631

Indirizzo

900 NORTH POINT PARKWAY, ALPHARETTA, GA

Dipendente

Cinguettio

@clearsidebio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

CLSD's Discussions on Twitter

Confronta CLSD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CLSD	1.02	75.49M	8.23M	-32.49M	-19.91M	-0.59
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-12-15	Ripresa	Wedbush	Outperform
2021-07-29	Iniziato	H.C. Wainwright	Buy
2020-05-13	Iniziato	ROTH Capital	Buy
2019-08-09	Downgrade	Needham	Buy → Hold
2018-11-05	Downgrade	Cowen	Outperform → Market Perform
2018-11-05	Downgrade	JP Morgan	Overweight → Underweight
2018-11-05	Downgrade	Stifel	Buy → Hold
2018-03-06	Reiterato	Needham	Buy
2017-05-25	Iniziato	JMP Securities	Mkt Outperform
2017-02-24	Iniziato	JP Morgan	Overweight
2016-11-10	Reiterato	Needham	Buy
2016-10-24	Reiterato	Stifel	Buy

Mostra tutto

Clearside Biomedical Inc Borsa (CLSD) Ultime notizie

06:03 AM

Clearside Biomedical’s (CLSD) Buy Rating Reaffirmed at HC Wainwright - Defense World

06:03 AM

02:36 AM

What is HC Wainwright's Forecast for CLSD FY2024 Earnings? - MarketBeat

02:36 AM

Nov 17, 2024

Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Significant Decline in Short Interest - MarketBeat

Nov 17, 2024

Nov 16, 2024

Clearside Biomedical's (CLSD) Buy Rating Reaffirmed at Chardan Capital - MarketBeat

Nov 16, 2024

Clearside Biomedical (NASDAQ:CLSD) Raised to Hold at StockNews.com - MarketBeat

Nov 16, 2024

All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy - MSN

Nov 16, 2024

Nov 15, 2024

Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024

Needham & Company LLC Reaffirms Buy Rating for Clearside Biomedical (NASDAQ:CLSD) - Defense World

Nov 15, 2024

Nov 14, 2024

Clearside Biomedical (NASDAQ:CLSD) Given Buy Rating at HC Wainwright - MarketBeat

Nov 14, 2024

Clearside Biomedical Announces Slight Revenue Increase in Third Quarter, Advances Wet AMD Treatment in Clinical Trial - Vision Monday

Nov 14, 2024

Nov 13, 2024

Earnings call: Clearside Biomedical reports progress in AMD treatment - Investing.com

Nov 13, 2024

Earnings call: Clearside Biomedical reports progress in AMD treatment By Investing.com - Investing.com Australia

Nov 13, 2024